Rampart Investment Management’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-592
Closed -$102K 396
2020
Q3
$102K Sell
592
-1,105
-65% -$174K 0.06% 252
2020
Q2
$208K Buy
1,697
+959
+130% +$111K 0.04% 375
2020
Q1
$76K Sell
738
-849
-53% -$112K 0.04% 382
2019
Q4
$225K Sell
1,587
-15
-0.9% -$1.91K 0.03% 439
2019
Q3
$191K Sell
1,602
-101
-6% -$12K 0.02% 441
2019
Q2
$232K Sell
1,703
-112
-6% -$15K 0.03% 426
2019
Q1
$257K Buy
1,815
+841
+86% +$110K 0.03% 412
2018
Q4
$110K Sell
974
-4,509
-82% -$516K 0.03% 389
2018
Q3
$114K Sell
5,483
-1,942
-26% -$220K 0.05% 377
2018
Q2
$844K Buy
7,425
+3,705
+100% +$443K 0.08% 290
2018
Q1
$456K Buy
3,720
+2,579
+226% +$307K 0.04% 355
2017
Q4
$127K Sell
1,141
-147
-11% -$15.8K 0.05% 385
2017
Q3
$129K Buy
1,288
+96
+8% +$9.85K 0.04% 425
2017
Q2
$123K Buy
1,192
+933
+360% +$89.9K 0.04% 417
2017
Q1
$24K Buy
+259
New +$21.6K 0.01% 435

Other funds holding VAR

Rampart Investment Management's VAR Position: Q4 2020 in Review

Rampart Investment Management sold out of Varian Medical Systems, Inc. (VAR) in Q4 2020, closing a stake of 592 shares — an estimated $102K sold.

Rampart Investment Management first reported a position in VAR in Q1 2017 and held it in 15 quarters. The position peaked at $844K in Q2 2018. 636 funds tracked by Wall St. Rank hold VAR as of Q4 2020.

  • Rampart Investment Management reported no remaining Varian Medical Systems, Inc. position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 592 Varian Medical Systems, Inc. shares in Q4 2020, an estimated $102K.
  • Rampart Investment Management first reported a position in Varian Medical Systems, Inc. in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Varian Medical Systems, Inc. position peaked at $844K in Q2 2018.
  • 636 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.